Stanford Cancer Institute

Congratulations to Stanford Cancer Institute member Michelle Monje, MD, PhD, on winning the Brain Prize 2025 for her pioneering work in Cancer Neuroscience. https://bit.ly/3DoLSx2 #BrainCancer Lundbeckfonden / Lundbeck Foundation

In an outstanding example of team science, Stanford researchers will lead a major multinational project to study biology of cancer development in blood. The International Consortium on a Cancer Biomarker for Early Detection (INTERCEPT) will investigate traditional and novel risk factors, including biomarkers, for several types of cancers in the United States, Ghana, Israel, Japan, and Taiwan. Among the unique strengths of the study are: its large size (3,840 participants); the inclusion of multiple forms of cancer; a diverse, multi-ethnic population; the parallel investigation of biology, and psychological and environmental risk factors, such as loneliness, mental health, well-being, and climate change. The study will also assess the association of genomic and immunologic biomarkers with cancer status. Professor of Medicine and Stanford Cancer Institute member Ann Hsing, PhD, is the PI of the project. Hsing and her team at Stanford, including 16 faculty and over 25 staff, will work with established U.S. and international collaborators. https://lnkd.in/gX-P-56z #CancerDetection

Beverly Mitchell, MD, the second and first female director of the Stanford Cancer Institute, was honored for her leadership and mentorship.?#hematology #leukemia?#WomensHistoryMonth #CancerResearch

The discovery that some malignant cancers form connections with the brain’s circuitry that help fuel tumor growth could help researchers better understand how to treat or stop the cancers altogether. Michelle Monje Julien Sage Watch: https://bit.ly/41EhXtW #BrainCancer #CancerReserach

Physician Natasha Steele, MD, MPH looks back to when she was both a medical resident and cancer patient — and how a fellow resident and cancer patient taught her to embrace life with no guarantee of what lies ahead. Read more: https://stan.md/3ETJ5fR #CancerPatient

After the study Jacqueline Aredo, MD, led showed that an immunotherapy drug did more harm than good for people with locally advanced EGFR mutated lung cancer -- aka never-smoker Lung Cancer -- this young doctor is taking another tack. Read more:https://stan.md/3ENv7Mf #LungCancer

A reconstructive surgeon uses the omentum, a fatty layer encasing the abdomen, to rebuild breasts after mastectomy, allowing for a faster recovery. Read more: https://stan.md/4gW83Zf #BreastCancer

When cancer patients’ view of their disease shifts from catastrophic to manageable, their physical experience of the disease improves. SCI members Lidia Schapira, MD, Alia Crum, PhD, Jonathan Berek, MD, and David Spiegel, MD, found watching a series of short documentary-style films helps them make the shift. Read more: https://stan.md/438AVds #MindSet

The?Stanford Translational Cardio-Oncology Program?focuses on reducing cardiotoxicity across?a spectrum of?cancer therapies. #CancerTreatment #chemotherapy

The state of cancer patients’ gut microbiome could be the key to why some patients respond better than others to CAR-T cell immunotherapy. SCI member Melody Smith, MD, MS, investigates. Read more: https://stan.md/41k3dR0 #immunotherapy